The first pill designed to treat symptomatic COVID has been approved by the UK medicine regulator. The tablet – Molnupiravir – will be given twice a day to vulnerable patients recently diagnosed with the disease. In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalization or death by about half.